ALERTS & COVID-19 UPDATES Learn more: COVID-19 Resources; COVID-19 Testing; Vaccine Info; Visitor Policy; Support Us

[LCID Study Number: 2017-026]

EA8143: A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients with Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)

The main objective of this study is to compare recurrence free survival between patients with renal cell carcinoma treated with nivolumab before resection surgery to patients who undergo surgery without nivolumab. Researchers will look for differences in survival associated with both treatment groups.

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-2734